HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response.

J. D. Boyer, Michael Anand Chattergoon, A. Shah, R. Ginsberg, R. R. MacGregor, D. B. Weiner

Research output: Contribution to journalArticle

Abstract

Novel approaches for the generation of more effective vaccines for HIV-1 are of significant importance. In this report we analyse the immunogenicity and efficacy of a DNA vaccination approach in a chimpanzee model system. Three chimpanzees were vaccinated with DNA constructs which express the env, rev, gag and pol proteins. These animals developed specific cellular responses to these proteins, although the nature of the responses varied among the animals. We demonstrated that DNA vaccination led to a CD8 mediated killing of targets expressing the homologous clade B envelope as well as targets expressing heterologous clade E envelope. In addition seronegative individuals have been inoculated with a DNA construct which expresses the env, rev proteins. These studies serve as an important benchmark for the use of DNA vaccine technology for the production of protective immune responses.

Original languageEnglish (US)
Pages (from-to)147-153
Number of pages7
JournalDevelopments in Biological Standardization
Volume95
StatePublished - 1998
Externally publishedYes

Fingerprint

DNA Vaccines
HIV-1
rev Gene Products
env Gene Products
Pan troglodytes
DNA
gag-pol Fusion Proteins
Vaccination
Benchmarking
Vaccines
Technology
Proteins

ASJC Scopus subject areas

  • Biotechnology

Cite this

Boyer, J. D., Chattergoon, M. A., Shah, A., Ginsberg, R., MacGregor, R. R., & Weiner, D. B. (1998). HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response. Developments in Biological Standardization, 95, 147-153.

HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response. / Boyer, J. D.; Chattergoon, Michael Anand; Shah, A.; Ginsberg, R.; MacGregor, R. R.; Weiner, D. B.

In: Developments in Biological Standardization, Vol. 95, 1998, p. 147-153.

Research output: Contribution to journalArticle

Boyer, JD, Chattergoon, MA, Shah, A, Ginsberg, R, MacGregor, RR & Weiner, DB 1998, 'HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response.', Developments in Biological Standardization, vol. 95, pp. 147-153.
Boyer, J. D. ; Chattergoon, Michael Anand ; Shah, A. ; Ginsberg, R. ; MacGregor, R. R. ; Weiner, D. B. / HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response. In: Developments in Biological Standardization. 1998 ; Vol. 95. pp. 147-153.
@article{2fcf3a65c94946e59b3959a9e324e2a1,
title = "HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response.",
abstract = "Novel approaches for the generation of more effective vaccines for HIV-1 are of significant importance. In this report we analyse the immunogenicity and efficacy of a DNA vaccination approach in a chimpanzee model system. Three chimpanzees were vaccinated with DNA constructs which express the env, rev, gag and pol proteins. These animals developed specific cellular responses to these proteins, although the nature of the responses varied among the animals. We demonstrated that DNA vaccination led to a CD8 mediated killing of targets expressing the homologous clade B envelope as well as targets expressing heterologous clade E envelope. In addition seronegative individuals have been inoculated with a DNA construct which expresses the env, rev proteins. These studies serve as an important benchmark for the use of DNA vaccine technology for the production of protective immune responses.",
author = "Boyer, {J. D.} and Chattergoon, {Michael Anand} and A. Shah and R. Ginsberg and MacGregor, {R. R.} and Weiner, {D. B.}",
year = "1998",
language = "English (US)",
volume = "95",
pages = "147--153",
journal = "Developments in Biological Standardization",
issn = "0301-5149",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response.

AU - Boyer, J. D.

AU - Chattergoon, Michael Anand

AU - Shah, A.

AU - Ginsberg, R.

AU - MacGregor, R. R.

AU - Weiner, D. B.

PY - 1998

Y1 - 1998

N2 - Novel approaches for the generation of more effective vaccines for HIV-1 are of significant importance. In this report we analyse the immunogenicity and efficacy of a DNA vaccination approach in a chimpanzee model system. Three chimpanzees were vaccinated with DNA constructs which express the env, rev, gag and pol proteins. These animals developed specific cellular responses to these proteins, although the nature of the responses varied among the animals. We demonstrated that DNA vaccination led to a CD8 mediated killing of targets expressing the homologous clade B envelope as well as targets expressing heterologous clade E envelope. In addition seronegative individuals have been inoculated with a DNA construct which expresses the env, rev proteins. These studies serve as an important benchmark for the use of DNA vaccine technology for the production of protective immune responses.

AB - Novel approaches for the generation of more effective vaccines for HIV-1 are of significant importance. In this report we analyse the immunogenicity and efficacy of a DNA vaccination approach in a chimpanzee model system. Three chimpanzees were vaccinated with DNA constructs which express the env, rev, gag and pol proteins. These animals developed specific cellular responses to these proteins, although the nature of the responses varied among the animals. We demonstrated that DNA vaccination led to a CD8 mediated killing of targets expressing the homologous clade B envelope as well as targets expressing heterologous clade E envelope. In addition seronegative individuals have been inoculated with a DNA construct which expresses the env, rev proteins. These studies serve as an important benchmark for the use of DNA vaccine technology for the production of protective immune responses.

UR - http://www.scopus.com/inward/record.url?scp=0032239137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032239137&partnerID=8YFLogxK

M3 - Article

C2 - 9855425

AN - SCOPUS:0032239137

VL - 95

SP - 147

EP - 153

JO - Developments in Biological Standardization

JF - Developments in Biological Standardization

SN - 0301-5149

ER -